Skip to content

ANNX - Annexon, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Annexon Inc

ANNX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ANNXAnnexon Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $7.18
52-wk low: $2.03
Prev close: $4.93
Mkt cap: $1.04B
Beta: 1.22
P/B: 5.4x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$297.0M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$16.2M
position
QR
Qube Research

Earnings

Reported Aug 12, 2026

Earnings came in 21.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.0B

Valuation

P/B5.38

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ANNX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.04B
Beta: 1.22

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-105.3%

Q2 2026 13F

$15.7M

position

P7

Point72

Steven Cohen · Q2 2026 13F

$7.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ANNX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.28-21.7%

-$0.23 expected

Next report

What the street expects next

EPS expected

-$0.26

-$0.30 to -$0.21

Revenue expected

$0.00

10 analysts

Last 30 days

4up0down

Analysts raising estimates

-105.3%

ROA-51.5%

Growth

Beta1.22